Calumet, Inc. (NASDAQ:CLMT – Get Free Report) has received an average recommendation of “Hold” from the eight brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $22.8333.
A number of analysts have recently issued reports on the stock. HC Wainwright reissued a “buy” rating and issued a $33.00 price objective on shares of Calumet in a research note on Monday, November 10th. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. TD Cowen restated a “hold” rating on shares of Calumet in a research report on Thursday, January 29th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, The Goldman Sachs Group lifted their target price on Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, January 30th.
Get Our Latest Research Report on Calumet
Institutional Trading of Calumet
Calumet Trading Up 2.7%
Shares of NASDAQ:CLMT opened at $29.50 on Friday. The stock has a 50 day moving average of $21.80 and a 200 day moving average of $19.25. The company has a market cap of $2.56 billion, a PE ratio of -68.60 and a beta of 1.24. Calumet has a 12-month low of $7.68 and a 12-month high of $29.92.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Featured Stories
- Five stocks we like better than Calumet
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
